MicroRNA-214 antagonism protects against renal fibrosis.
about
MicroRNAs in fibrosis: opportunities and challengesMicroRNAs in acute kidney injuryRegulation and function of miR-214 in pulmonary arterial hypertension.MicroRNA function in the profibrogenic interplay upon chronic liver disease.Anti-fibrotic Role of miR-214 in Thioacetamide-induced Liver Cirrhosis in Rats.Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.MicroRNA-150 deletion in mice protects kidney from myocardial infarction-induced acute kidney injury.MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.MicroRNA-214 Mediates Isoproterenol-induced Proliferation and Collagen Synthesis in Cardiac Fibroblasts.Identification of side- and shear-dependent microRNAs regulating porcine aortic valve pathogenesis.Cross talk between miR-214 and PTEN attenuates glomerular hypertrophy under diabetic conditions.MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.miR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction.Inhibition of SRF/myocardin reduces aortic stiffness by targeting vascular smooth muscle cell stiffening in hypertension.Baicalin ameliorates renal fibrosis via inhibition of transforming growth factor β1 production and downstream signal transduction.Renal allograft fibrosis: biology and therapeutic targets.Role of Smad signaling in kidney disease.microRNA and Kidney Transplantation.Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.Epigenetics in Reactive and Reparative Cardiac Fibrogenesis: The Promise of Epigenetic Therapy.Noncoding RNA and epigenetic gene regulation in renal diseases.Novel Anti-fibrotic Therapies.Epigenetic repression of Krüppel-like factor 4 through Dnmt1 contributes to EMT in renal fibrosis.Inhibition of microRNA-214 promotes epithelial-mesenchymal transition process and induces interstitial cystitis in postmenopausal women by upregulating Mfn2.miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy.Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion.Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms.MicroRNA-214 exerts a Cardio-protective effect by inhibition of fibrosis.MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression.The Lhx1-Ldb1 complex interacts with Furry to regulate microRNA expression during pronephric kidney developmentmiR-214 ameliorates acute kidney injury via targeting DKK3 and activating of Wnt/β-catenin signaling pathway
P2860
Q28067380-5881C0AE-463F-4504-9C5B-C7A502DB3E4FQ28069749-D99813C1-F796-48D1-94C9-53A70FE7481AQ32884388-D8FE6534-2F4F-4DF1-BF22-F9B6B17F8ABBQ33907481-BB161F53-967A-4340-BE6E-119AF1F7B94EQ35574298-B7D2C2E8-F90E-475F-ABA2-C2889C57FFDBQ35580945-B0E7B6E2-38AA-47EC-A411-9A180C38D964Q36066385-BA2838CA-C7D6-4023-BC0F-B7CF4A7448FCQ36166755-5B26E9E7-643C-44AA-9F1D-158C6A4CE738Q36392780-47098A59-CA0A-4C16-88E9-205C5D9E4A94Q36875505-4B526926-F289-43E9-82D3-50BDAF73CF2BQ37195490-E4C9D9E9-F4AC-43D5-A144-82B3201C0F42Q37211825-60BA000D-A974-400C-9456-A9FEFB1299FCQ37681848-717DD389-9662-4F14-8837-B784741E1E60Q37684462-856120B4-6565-4A83-81E5-BBE1E53DF63DQ37720211-4B070D52-1D3F-4C31-81FD-11A761833EA2Q38359455-DB20689D-056B-4963-BAAB-FEF8FB4BE7B0Q38598542-4694E84C-CB7C-49F0-93FB-5C7A830D21C6Q38668263-49D7E5E1-35C1-4D48-9EB3-8DEF92DDCC5DQ38858897-6641A845-D8A8-4135-BC82-9BE78AFC9D88Q39018712-604D271A-EFC1-4B54-8532-76C6AEF69880Q39294086-CB05E343-AEC7-457F-9EFC-2E20B146B07DQ39377055-7E1D5CB5-6CD3-42ED-8F8C-E641008C25D3Q40701780-19A7F414-3DA6-4CC2-BB04-6D0C9A4D28DCQ41480555-1D17CAB0-1F23-4016-993A-C76D91DDD45BQ42140252-F7936DA5-C9BB-4152-9CD4-226A4D08E4E7Q47828965-DB61BD30-EE2C-4D83-AC02-BBD0DA5AFADBQ50063239-EF449360-3605-4726-896C-6EA8CDF909C2Q50175524-62B3426F-1747-463A-93DA-12DDA15265D4Q51673274-0DD3F16A-FD6E-45ED-AC1D-D5A15D52E6B5Q55400535-BB5D2EF9-4003-4E57-BF1B-91296E7A18BAQ58099129-EAA1B001-28FB-43CE-8691-FB9828B6DB0EQ58765739-59AA1BC3-D3D8-4039-A62D-95E8423F053E
P2860
MicroRNA-214 antagonism protects against renal fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA-214 antagonism protects against renal fibrosis.
@en
MicroRNA-214 antagonism protects against renal fibrosis.
@nl
type
label
MicroRNA-214 antagonism protects against renal fibrosis.
@en
MicroRNA-214 antagonism protects against renal fibrosis.
@nl
prefLabel
MicroRNA-214 antagonism protects against renal fibrosis.
@en
MicroRNA-214 antagonism protects against renal fibrosis.
@nl
P2093
P2860
P356
P1476
MicroRNA-214 antagonism protects against renal fibrosis.
@en
P2093
Andrew H Baker
Arin B Aurora
Brent Dickinson
Bryan R Conway
Christian Delles
David Kipgen
Eva van Rooij
Jennifer S Grant
John D McClure
Laura Denby
P2860
P356
10.1681/ASN.2013010072
P577
2013-10-24T00:00:00Z